3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
10
Lymphoma
5
Neoplasms, Germ Cell and Embryonal
3
Seminoma
2
Vulvar Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Neoplasms, Second Primary
1
Neoplasms
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Hemangioma, Capillary
1
Endodermal Sinus Tumor
1
Desmoid Tumors
1
Carcinoma, Embryonal
1
Interventions
Cyclophosphamide
9
glofitamab
4
Whole-Body Irradiation
4
Rituximab
4
fludarabine phosphate
3
fludarabine
3
Mycophenolic Acid
3
Melphalan
3
Doxorubicin
3
polatuzumab vedotin
2
pirtobrutinib
2
pembrolizumab
2
obinutuzumab
2
Tacrolimus
2
Sirolimus
2
Prednisone
2
Busulfan
2
zanubrutinib
1
venetoclax
1
relmacabtagene autoleucel
1
pegfilgrastim
1
axicabtagene ciloleucel
1
Vincristine
1
Triamcinolone
1
Specimen Handling
1
Receptors, Chimeric Antigen
1
Prednisolone
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Methotrexate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Dendritic Cell Sarcoma, Interdigitating
×
Bleomycin
×
1 year
×
Clear all
No trials found.